WIDESPREAD INTRADERMAL ACCUMULATION OF MONONUCLEAR LEUKOCYTES IN LEPROMATOUS LEPROSY PATIENTS TREATED SYSTEMICALLY WITH RECOMBINANT INTERFERON-GAMMA

被引:28
作者
NATHAN, C
SQUIRES, K
GRIFFO, W
LEVIS, W
VARGHESE, M
JOB, CK
NUSRAT, AR
SHERWIN, S
RAPPOPORT, S
SANCHEZ, E
BURKHARDT, RA
KAPLAN, G
机构
[1] US PHS,BAYLEY SETON HOSP,HANSENS DIS CTR,STATEN ISL,NY 10304
[2] ROCKEFELLER UNIV,CELLULAR PHYSIOL & IMMUNOL LAB,NEW YORK,NY 10021
[3] GENENTECH INC,S SAN FRANCISCO,CA 94080
[4] CORNELL UNIV,MED CTR,DEPT MED,DIV DERMATOL,NEW YORK,NY 10021
[5] CORNELL UNIV,MED CTR,DEPT MED,DIV INFECT DIS,NEW YORK,NY 10021
[6] CORNELL UNIV,MED CTR,DEPT MED,DIV DERMATOL,NEW YORK,NY 10021
关键词
D O I
10.1084/jem.172.5.1509
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intradermal administration ofrecombinant interferon γ(rIFN-γ) to lepromatous leprosy patients has converted the local histology toward a tuberculoid pattern. However, such changes have been confined to the site of injection. In contrast, in the present study, marked, intradermal accumulation of CD3+, CD4+, CD8+, and CD1a+ T cells and Leu-M5+ mononuclear phagocytes was induced at a distance from the sites of administration, in a dose-dependent manner, by 10 daily intramuscular injections of 10-30 μg rIFN-γ/m2. Mononuclear cell infiltration began within 3 d of onset of rIFN-γ therapy and persisted at least 8 wk. Intramuscular administration of rIFN-γ to lepromatous patients receiving concurrent chemotherapy can safely induce widespread histologic features of an upgrading reaction. © 1990, Rockefeller University Press., All rights reserved.
引用
收藏
页码:1509 / 1512
页数:4
相关论文
共 50 条
  • [41] Altered synthesis of interferon-gamma and expression of interferon-gamma receptor by peripheral blood mononuclear cells from patients with IgA nephropathy and non-IgA proliferative glomerulonephritis
    Yano, N
    Endoh, M
    Naka, R
    Takemura, F
    Nomoto, Y
    Sakai, H
    JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (01) : 71 - 79
  • [42] INTRADERMAL RECOMBINANT INTERLEUKIN-2 ENHANCES PERIPHERAL-BLOOD T-CELL RESPONSES TO MITOGEN AND ANTIGENS IN PATIENTS WITH LEPROMATOUS LEPROSY
    CONVERSE, P
    OTTENHOFF, THM
    TEKLEMARIAM, SW
    HANCOCK, GE
    DIETZ, M
    BECXBLEUMINK, M
    WONDIMU, A
    KIESSLING, R
    COHN, ZA
    KAPLAN, G
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (02) : 83 - 91
  • [43] RECOMBINANT PORCINE INTERFERON-GAMMA ACTIVATES INVITRO PORCINE ADHERENT MONONUCLEAR-CELLS TO PRODUCE INTERLEUKIN-1
    CHARLEY, B
    LAVERNE, S
    LAVENANT, L
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 25 (02) : 117 - 124
  • [44] ORGAN SPECIFIC CYTOKINE THERAPY - LOCAL ACTIVATION OF MONONUCLEAR PHAGOCYTES BY DELIVERY OF AN AEROSOL OF RECOMBINANT INTERFERON-GAMMA TO THE HUMAN LUNG
    JAFFE, HA
    BUHL, R
    MASTRANGELI, A
    HOLROYD, KJ
    SALTINI, C
    CZERSKI, D
    JAFFE, HS
    KRAMER, S
    SHERWIN, S
    CRYSTAL, RG
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) : 297 - 302
  • [45] Recombinant interleukin-2 in combination with recombinant interferon-gamma in patients with advanced malignancy: A Phase 1 study
    Reddy, SP
    Harwood, RM
    Moore, DF
    Grimm, EA
    Murray, JL
    VadhanRaj, S
    JOURNAL OF IMMUNOTHERAPY, 1997, 20 (01): : 79 - 87
  • [46] A PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-2 COMBINED WITH RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH CANCER
    REDMAN, BG
    FLAHERTY, L
    CHOU, TH
    ALKATIB, A
    KRAUT, M
    MARTINO, S
    CHEN, B
    KAPLAN, J
    VALDIVIESO, M
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) : 1269 - 1276
  • [47] INCREASED SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA BY MONONUCLEAR LEUKOCYTES IN PATIENTS WITH ISCHEMIC-HEART-DISEASE - RELEVANCE IN SUPEROXIDE ANION GENERATION
    VADDI, K
    NICOLINI, FA
    MEHTA, P
    MEHTA, JL
    CIRCULATION, 1994, 90 (02) : 694 - 699
  • [48] A PILOT-STUDY OF RECOMBINANT HUMAN TNF AND INTERFERON-GAMMA IN 4 PATIENTS WITH REFRACTORY AML
    FIEDLER, W
    WEH, HJ
    HOSSFELD, DK
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 48 (02) : 115 - 116
  • [49] SERIAL INTERFERON-GAMMA RELEASE ASSAYS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC AGENTS
    Huang, Y. J.
    Fang, Y. F.
    Chen, Y. F.
    Tsai, P. H.
    Kuo, C. F.
    Yu, K. H.
    Luo, S. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 333 - 333
  • [50] In vivo induction of HLA-DR on human neutrophils in patients treated with interferon-gamma
    Reinisch, W
    Tillinger, W
    Lichtenberger, C
    Gangl, A
    Willheim, M
    Scheiner, O
    Steger, G
    BLOOD, 1996, 87 (07) : 3068 - 3068